NREP
NEW REPRESENTATIVE AT IB RECEIVED
05/07/2020
Back to search
Official data from USPTO
GENE SIGNAL
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
51
Latest update
05/07/2020
Trademark type
Combined
Nice classes
1, 5, 42
Filing date
11/14/2006
Registration date
09/09/2008
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/12/2019
Last transaction
04/12/2019
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
3
Owner type
98
Owner location
Epalinges, CH
Examiner
BUNCH, TASHIA AUNGELIK
Law office
L50
Mark description
The mark consists of the wording "GENE SIGNAL". The "S" in "SIGNAL" is contained within a rectangle with three curved lines above and below it.
Holders and representatives
Holders
Gene Signal International SA
Gene Signal International SA
Representatives
Thomas W. Brooke Holland & Knight LLP
Technical classification
Nice Classes
Class 1Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
chemicals for use in science; chemical preparations for scientific applications; biotechnological productssubstances for use in the scientific research and development of medicines for the treatment of eye conditionsskin conditionscancerfor the controlling and affecting angiogenesis
Class 5
chemicalpharmaceutical and biotechnological preparations for medical and pharmaceutical purposespreparations for the treatment of eye conditionsskin conditionscancerfor controlling and affecting angiogenesis; pharmaceutical preparations for the treatment of pathologies linked to angiogenesis; therapeutic preparations for the treatment of pathologies linked to angiogenesis
Class 42
Scientific research for medical purposesresearch and engineering in the medicalpharmaceuticalchemical and biotechnological fieldsresearch and development of therapeutic products and preparations intended for pathologies linked among other things to angiogenesis
Publications
History of USPTO decisions and trademark events.
51 publications found
INNT
TOTAL INVALIDATION PROCESSED BY THE IB
02/07/2020
INTS
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
01/10/2020
INPC
INVALIDATION PROCESSED
01/10/2020
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
12/12/2019
C71T
CANCELLED SECTION 71
04/12/2019
NREP
NEW REPRESENTATIVE AT IB RECEIVED
11/15/2018
REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
09/09/2017
RNWL
INTERNATIONAL REGISTRATION RENEWED
12/15/2016
NREP
NEW REPRESENTATIVE AT IB RECEIVED
03/03/2016
INNP
PARTIAL INVALIDATION PROCESSED BY THE IB
09/11/2015
INPS
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
07/30/2015
INPC
INVALIDATION PROCESSED
07/30/2015
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
05/05/2015
NA75
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
09/05/2014
C75P
REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.
09/05/2014
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/05/2014
ES75
TEAS SECTION 71 & 15 RECEIVED
09/02/2014
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
04/14/2013
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
08/12/2010
NREP
NEW REPRESENTATIVE AT IB RECEIVED
07/29/2010
NREP
NEW REPRESENTATIVE AT IB RECEIVED
05/13/2010
NREP
NEW REPRESENTATIVE AT IB RECEIVED
02/20/2009
FICS
FINAL DISPOSITION NOTICE SENT TO IB
01/06/2009
FIMP
FINAL DISPOSITION PROCESSED
01/06/2009
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
12/09/2008
R.PR
REGISTERED-PRINCIPAL REGISTER
09/09/2008
PUBO
PUBLISHED FOR OPPOSITION
06/24/2008
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
06/05/2008
NPUB
NOTICE OF PUBLICATION
06/04/2008
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
05/22/2008
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
05/22/2008
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
05/20/2008
ALIE
ASSIGNED TO LIE
05/20/2008
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/20/2008
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/22/2008
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/21/2008
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
04/21/2008
CNFR
FINAL REFUSAL MAILED
10/22/2007
CNFR
FINAL REFUSAL WRITTEN
10/19/2007
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/29/2007
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/28/2007
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/28/2007
RFNT
REFUSAL PROCESSED BY IB
04/19/2007
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
04/02/2007
RFRR
REFUSAL PROCESSED BY MPU
04/02/2007
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
03/30/2007
CNRT
NON-FINAL ACTION WRITTEN
03/29/2007
DOCK
ASSIGNED TO EXAMINER
03/19/2007
NWAP
NEW APPLICATION ENTERED
12/22/2006
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
12/21/2006
Continuous trademark protection
Get notified about every new filing that threatens GENE SIGNAL or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.